Søgning


Flere søgeindstillinger

Søgning på udtrykket 'tobramycin' giver 10 resultater


Nyt fra tidsskrifterne [10]
Nyt fra tidsskrifterne [10]
International Journal of Infectious Diseases
24.04.2025
Diffuse panbronchiolitis (DPB), a chronic inflammatory disease of the small airways predominantly affecting East Asians. It is characterized by persistent Pseudomonas aeruginosa colonization, recurrent respiratory infections, and progressive respiratory failure. The 10-year survival rate is reported to exceed 90% with long-term erythromycin therapy; however, outcomes are significantly worse in patients infected with P.
Antimicrobial Agents And Chemotherapy
15.04.2025
Antimicrobial Agents and Chemotherapy, Ahead of Print.
PLoS One Infectious Diseases
11.02.2025
…mm2 surface area of Staphylococcus aureus and Pseudomonas aeruginosa biofilms were comparable on beads and CDC Biofilm Reactor® coupons. In this study, we hypothesized that biofilms grown on beads would be more susceptible to ertapenem, moxifloxacin, and tobramycin than those grown on coupons. Results indicated a significant reduction in S. aureus bioburden on glass beads compared to glass coupons following treatment with ertapenem (p = 0.005) and tobramycin (p = 0.014). P.
Infection
6.03.2025
…In this study, SDD containing colistin, tobramycin, and nystatin was administered to eight patients with recurrent cholangitis, and the incidence density before and after SDD administration was analyzed. . Results. The overall incidence density of cholangitis requiring hospital admission was 0.37 per 100 patient days during the SDD period and was significantly lower than observed before SDD administration (1.05 per 100 patient days) [RR: 0.35 (95% CI: 0.21–0.59); p:
BMC Infectious Diseases
1.03.2025
…d 57.6% (n = 68) were identified as MRSA and MSSA, respectively. All MRSA isolates were mecA-positive. Among MRSA isolates, SCCmec type IVa (17; 34%) was predominant, followed by types IVc, V, III, II, and I. Resistance rates to gentamicin, kanamycin, tobramycin, and amikacin were 16.1%, 17.8%, 8.5%, and 8.5%, respectively. Overall, the aminoglycoside resistance and most non-aminoglycoside antibiotics were significantly higher in MRSA versus MSSA isolates.
Infection
22.02.2025
… involving oral nonabsorbable antibiotics has been primarily applied to children undergoing Kasai portoenterostomy surgery. . . . Methods. In this study, SDD containing colistin, tobramycin, and nystatin was administered to eight patients with recurrent cholangitis, and the incidence density before and after SDD administration was analyzed. . . . Results.
BMC Infectious Diseases
4.01.2025
. Abstract. . Background. In clinical practice, the emergence of ST11-K64 carbapenem-resistant Klebsiella pneumoniae (ST11-K64 CRKP) has become increasingly alarming. Despite this trend, limited research has been conducted to elucidate the clinical and molecular characteristics of these strains. . . . Objectives.
BMC Infectious Diseases
17.07.2024
…in patients referred to Ardabil hospitals. . . . Methods. A total of 200 isolates from five hospitals were evaluated. The resistance profiles of P. aeruginosa isolates to tobramycin, amikacin, and netilmicin were determined using the disk diffusion method.
BMC Infectious Diseases
26.06.2024
…tibility index were determined via the MTT, LDH, and ROS formation assays. . . . Results. Ampicillin, ceftazidime, and colistin were the least effective, and amikacin and tobramycin were the most effective antibiotics. Out of the 60 isolates, 10 (16.7%), 5 (8.3%), and 45 (75%) were multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR), respectively.
BMC Infectious Diseases
18.05.2024
. Abstract. . Background. The study aims were to evaluate the species distribution and antimicrobial resistance profile of Gram-negative pathogens isolated from specimens of intra-abdominal infections (IAI), urinary tract infections (UTI), respiratory tract infections (RTI), and blood stream infections (BSI) in emergency departments (EDs) in China. . . .

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2025 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.2.1
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 1.274 s

Cookies og privatliv